HOCHICEF

This brand name is authorized in Nigeria.

Active ingredients

The drug HOCHICEF contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7193	Injection	HOCHICEF INJECTION INJ 1 g 1VIAL X 2AMPOULES	17 RNW-PP-276645 Hochicef Injection CEFTRIAXONE SODIUM FOR INJECTION 1G Each vial contains: Ceftriaxone Sodium eq. to Ceftriaxone 1g B4-7193 Drugs Imported Products 1VIAL2AMPOULES Prescription Only Medicine (POM) 8/5/2022 HOCHIEZ PHARMACEUTICAL NIG. LTD., PALM AVENUE, MUSHIN. LAGOS. LAGOS 8033024651 hochiez@yahoo.com Shandong Xier Kangtai Pharmaceuticals Co. Ltd, PRIVATE ECONOMY GARDEN, XINYAN TOWN, YANZHOU, JINING CITY, SHANDONG, CHINA, China	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7193